subject: Aarkstore Enterprise - Novabay Pharmaceuticals, Inc. (nby) - Financial And Strategic Analysis Review [print this page] NovaBay Pharmaceuticals, IncNovaBay Pharmaceuticals, Inc. (NovaBay) is a publicly held biopharmaceutical company. It is focused on developing innovative product candidates targeting the treatment of infectious disease. NovaBay has developed its aganocide compounds through research and development based on the human body's natural immune system and the molecules involved in combating infections. The companys aganocide compounds are synthetic forms of N-chlorinated antimicrobial molecules, which are effective and acting anti-infective molecules produced by white blood cells when defending the body against invading pathogens.
NovaBay Pharmaceuticals, Inc. Key Recent Developments
May 06, 2010: NovaBay Announces Positive Data On New Class of Anti-infectives At ARVO 2010
Dec 17, 2009: Alcon Increases Financial Support For NovaBay
Oct 30, 2009: NovaBay's Aganocide Shows Efficacy In Pre-Clinical Infected Human Nail Model Of Onychomycosis
Oct 19, 2009: NovaBay Names Mark Anderson As Chief Scientific Officer
Oct 19, 2009: NovaBay Names Mark Anderson As Chief Scientific Officer
This comprehensive SWOT profile of NovaBay Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of NovaBay Pharmaceuticals, Inc., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
